These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 23550448
21. [Treatment strategy for marginally resectable GIST]. Kanda T, Ishikawa T, Ozaki T, Yajima K, Kosugi S, Hatakeyama K. Gan To Kagaku Ryoho; 2011 Aug; 38(8):1266-70. PubMed ID: 21829064 [Abstract] [Full Text] [Related]
22. Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST. Gasparotto D, Miolo G, Torrisi E, Canzonieri V, Bertola G, Libra M, Marzotto A, Maestro R, Buonadonna A. Int J Colorectal Dis; 2014 May; 29(5):639-40. PubMed ID: 24525699 [No Abstract] [Full Text] [Related]
23. Gastrointestinal stromal tumor: 5 years later. van der Zwan SM, DeMatteo RP. Cancer; 2005 Nov 01; 104(9):1781-8. PubMed ID: 16136600 [Abstract] [Full Text] [Related]
24. Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy. Jamali FR, Darwiche SS, El-Kinge N, Tawil A, Soweid AM. Oncologist; 2007 Apr 01; 12(4):438-42. PubMed ID: 17470686 [Abstract] [Full Text] [Related]
27. Gastrointestinal stromal tumor of colon: a case report and review of literature. Niazi AK, Kaley K, Saif MW. Anticancer Res; 2014 May 01; 34(5):2547-50. PubMed ID: 24778074 [Abstract] [Full Text] [Related]
28. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Fiore M, Palassini E, Fumagalli E, Pilotti S, Tamborini E, Stacchiotti S, Pennacchioli E, Casali PG, Gronchi A. Eur J Surg Oncol; 2009 Jul 01; 35(7):739-45. PubMed ID: 19110398 [Abstract] [Full Text] [Related]
29. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment. Yeh CN, Chen TW, Tseng JH, Liu YY, Wang SY, Tsai CY, Chiang KC, Hwang TL, Jan YY, Chen MF. J Surg Oncol; 2010 Nov 01; 102(6):599-603. PubMed ID: 20976730 [Abstract] [Full Text] [Related]
33. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY. Chin Med J (Engl); 2010 Jan 20; 123(2):131-6. PubMed ID: 20137358 [Abstract] [Full Text] [Related]
34. [Surgical treatment of an advanced GIST the age of imatinib]. Fernández JA, Parrilla P. Cir Esp; 2009 Jul 20; 86(1):3-12. PubMed ID: 19539273 [Abstract] [Full Text] [Related]
35. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G, Niebel W, Erhard J, Ebeling P, Zeth M, Taeger G, Seeber S, Flasshove M, Schütte J. Int J Cancer; 2005 Nov 01; 117(2):316-25. PubMed ID: 15900603 [Abstract] [Full Text] [Related]
36. Duodenal gastrointestinal stromal tumors: review on clinical and surgical aspects. Cavallaro G, Polistena A, D'Ermo G, Pedullà G, De Toma G. Int J Surg; 2012 Nov 01; 10(9):463-5. PubMed ID: 22939976 [Abstract] [Full Text] [Related]
39. Hepatic metastasis with heterologous rhabdomyoblastic differentiation in a patient with gastrointestinal stromal tumor treated with imatinib. Vij M, Patra S, Rela M. Indian J Pathol Microbiol; 2013 Nov 01; 56(3):291-3. PubMed ID: 24152514 [Abstract] [Full Text] [Related]